About 14 results found for searched term "85-61-0" (0.053 seconds)
Cat.No. | Name | Target |
---|---|---|
M8094 | PF-06761281 | Others |
PF-06761281 is an inhibitor of the sodium-coupled citrate transporter (NaCT or SLC13A5), which may be a target for tretment and prevention of metabolic disorders. | ||
M11468 | Coenzyme A | Metabolite/Endogenous Metabolite |
Coenzyme A is an essential cofactor in all living cells synthesized by Vitamin B5, ATP, and cysteine. | ||
M24967 | Nurulimab | Others |
BCD-145 | ||
Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) humanized monoclonal antibody. Nurulimab can be can be used in research of melanoma. | ||
M30908 | BRAF inhibitor | Raf |
BRAF inhibitor is a B-Raf inhibitor. | ||
M39401 | Fmoc-Phe(4-Br)-OH | Amino Acid Derivatives |
Fmoc-Phe(4-Br)-OH is a phenylalanine derivative that can be used for compound synthesis. | ||
M39514 | Fmoc-Pra-OH | Amino Acid Derivatives |
Fmoc-Pra-OH is a Glycine derivative. | ||
M41173 | BILB 1941 | Anti-infection |
BILB 1941 is a potent and specific nonnucleoside inhibitor of the hepatitis C virus (HCV) RNA polymerase in vitro. | ||
M43035 | Rocbrutinib | Others |
Rocbrutinib is a Bruton's tyrosine kinase inhibitor with antineoplastic effect. | ||
M50400 | PKI (14-24)amide | PKA |
PKI (14-24)amide is a potent PKA inhibitor. | ||
M50892 | H-Pro-Pro-Gln-OH | Others |
H-Pro-Pro-Gln-OH is a oligopeptide with excellent dipeptidyl peptidase-IV (DPP-IV) inhibitory activity. | ||
M51026 | Acetyl-PHF6YA amide | Others |
Acetyl-PHF6YA amide is a polypeptide that can be found by peptide screening. | ||
M51504 | SIYRY | Others |
SIYRY is a Kb-restricted epitope peptide. | ||
M52263 | (S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-methylbutanoate | Amino Acid Derivatives |
(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-methylbutanoate is a valine derivative. | ||
M57787 | (R)-2-undecanol | Others |
(R)-2-undecanol |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.